Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma

J Clin Oncol. 2009 Nov 10;27(32):e189-90; author reply e191. doi: 10.1200/JCO.2009.23.9731. Epub 2009 Oct 5.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Humans
  • Lymphoma, Mantle-Cell / drug therapy*
  • Prednisolone / administration & dosage
  • Prognosis
  • Survival Analysis
  • Time Factors
  • Treatment Outcome
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone